Vp Of Intellectual Property
CurrentThe Hobart Group accelerates ideas and develops and commercializes medical technologies targeting top healthcare markets with significant unmet needs. The growing portfolio of companies covers the areas of cardiology, diabetes, oncology, neurology and rehabilitation. Together, Hobart Group companies have over 200 scientists, engineers, regulatory and business experts across four continents, and benefit from the group’s clinical expertise and extensive regulatory and international market knowledge across Europe, the USA and Asia. For more information please visit www.Hobart-Group.com